nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER4—pleura—chronic obstructive pulmonary disease	0.193	0.555	CbGeAlD
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.036	0.16	CbGpPWpGaD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.0296	0.132	CbGpPWpGaD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.0273	0.122	CbGpPWpGaD
Misoprostol—PTGER4—respiratory system—chronic obstructive pulmonary disease	0.0192	0.0552	CbGeAlD
Misoprostol—PTGER4—connective tissue—chronic obstructive pulmonary disease	0.0169	0.0486	CbGeAlD
Misoprostol—PTGER3—respiratory system—chronic obstructive pulmonary disease	0.0162	0.0467	CbGeAlD
Misoprostol—PTGER4—bronchus—chronic obstructive pulmonary disease	0.0158	0.0454	CbGeAlD
Misoprostol—PTGER4—smooth muscle tissue—chronic obstructive pulmonary disease	0.0154	0.0444	CbGeAlD
Misoprostol—PTGER2—trachea—chronic obstructive pulmonary disease	0.0144	0.0415	CbGeAlD
Misoprostol—PTGER3—connective tissue—chronic obstructive pulmonary disease	0.0143	0.0411	CbGeAlD
Misoprostol—PTGER3—smooth muscle tissue—chronic obstructive pulmonary disease	0.0131	0.0376	CbGeAlD
Misoprostol—PTGER2—lung—chronic obstructive pulmonary disease	0.0104	0.0298	CbGeAlD
Misoprostol—PTGER4—lung—chronic obstructive pulmonary disease	0.0102	0.0293	CbGeAlD
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00879	0.0392	CbGpPWpGaD
Misoprostol—PTGER3—lung—chronic obstructive pulmonary disease	0.00863	0.0248	CbGeAlD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00722	0.0322	CbGpPWpGaD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00666	0.0297	CbGpPWpGaD
Misoprostol—PTGER4—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.00625	0.0278	CbGpPWpGaD
Misoprostol—PTGER2—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.00513	0.0229	CbGpPWpGaD
Misoprostol—PTGER4—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.00316	0.0141	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.0028	0.0125	CbGpPWpGaD
Misoprostol—PTGER2—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.0026	0.0116	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.0024	0.0107	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.0023	0.0103	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00229	0.0102	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00212	0.00946	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00197	0.00879	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00183	0.00815	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00182	0.00811	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00176	0.00783	CbGpPWpGaD
Misoprostol—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.00157	0.00368	CcSEcCtD
Misoprostol—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00365	CcSEcCtD
Misoprostol—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00365	CcSEcCtD
Misoprostol—Neuropathy—Prednisolone—chronic obstructive pulmonary disease	0.00155	0.00362	CcSEcCtD
Misoprostol—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00153	0.00359	CcSEcCtD
Misoprostol—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00153	0.00358	CcSEcCtD
Misoprostol—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00354	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00151	0.00671	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.0015	0.00669	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.0015	0.00667	CbGpPWpGaD
Misoprostol—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00148	0.00347	CcSEcCtD
Misoprostol—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.00148	0.00345	CcSEcCtD
Misoprostol—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.00345	CcSEcCtD
Misoprostol—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00147	0.00344	CcSEcCtD
Misoprostol—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00147	0.00344	CcSEcCtD
Misoprostol—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00146	0.00342	CcSEcCtD
Misoprostol—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00145	0.00339	CcSEcCtD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00144	0.00643	CbGpPWpGaD
Misoprostol—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00143	0.00333	CcSEcCtD
Misoprostol—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00142	0.00333	CcSEcCtD
Misoprostol—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.00331	CcSEcCtD
Misoprostol—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00141	0.00331	CcSEcCtD
Misoprostol—Shock—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00328	CcSEcCtD
Misoprostol—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.0014	0.00328	CcSEcCtD
Misoprostol—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.0014	0.00328	CcSEcCtD
Misoprostol—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.0014	0.00328	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00139	0.00617	CbGpPWpGaD
Misoprostol—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.00323	CcSEcCtD
Misoprostol—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00138	0.00323	CcSEcCtD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00137	0.00612	CbGpPWpGaD
Misoprostol—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00319	CcSEcCtD
Misoprostol—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00319	CcSEcCtD
Misoprostol—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00136	0.00318	CcSEcCtD
Misoprostol—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00135	0.00316	CcSEcCtD
Misoprostol—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00135	0.00315	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00135	0.006	CbGpPWpGaD
Misoprostol—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00135	0.00315	CcSEcCtD
Misoprostol—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00314	CcSEcCtD
Misoprostol—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00314	CcSEcCtD
Misoprostol—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00134	0.00313	CcSEcCtD
Misoprostol—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00312	CcSEcCtD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00133	0.00594	CbGpPWpGaD
Misoprostol—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00133	0.00312	CcSEcCtD
Misoprostol—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00309	CcSEcCtD
Misoprostol—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00305	CcSEcCtD
Misoprostol—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00303	CcSEcCtD
Misoprostol—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00301	CcSEcCtD
Misoprostol—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00129	0.00301	CcSEcCtD
Misoprostol—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.00301	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00128	0.00571	CbGpPWpGaD
Misoprostol—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00299	CcSEcCtD
Misoprostol—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00299	CcSEcCtD
Misoprostol—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.00297	CcSEcCtD
Misoprostol—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00125	0.00293	CcSEcCtD
Misoprostol—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00293	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00124	0.00551	CbGpPWpGaD
Misoprostol—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00289	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00123	0.00548	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.00286	CcSEcCtD
Misoprostol—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00284	CcSEcCtD
Misoprostol—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00282	CcSEcCtD
Misoprostol—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00277	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00118	0.00525	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.00273	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00116	0.00519	CbGpPWpGaD
Misoprostol—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00269	CcSEcCtD
Misoprostol—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00268	CcSEcCtD
Misoprostol—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00268	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00115	0.00511	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00114	0.00509	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00114	0.00506	CbGpPWpGaD
Misoprostol—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00265	CcSEcCtD
Misoprostol—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00265	CcSEcCtD
Misoprostol—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00265	CcSEcCtD
Misoprostol—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00265	CcSEcCtD
Misoprostol—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00265	CcSEcCtD
Misoprostol—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00265	CcSEcCtD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00113	0.00503	CbGpPWpGaD
Misoprostol—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00264	CcSEcCtD
Misoprostol—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00264	CcSEcCtD
Misoprostol—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00264	CcSEcCtD
Misoprostol—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00264	CcSEcCtD
Misoprostol—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00263	CcSEcCtD
Misoprostol—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00263	CcSEcCtD
Misoprostol—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00259	CcSEcCtD
Misoprostol—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00259	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00111	0.00493	CbGpPWpGaD
Misoprostol—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00258	CcSEcCtD
Misoprostol—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00258	CcSEcCtD
Misoprostol—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00257	CcSEcCtD
Misoprostol—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00254	CcSEcCtD
Misoprostol—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00254	CcSEcCtD
Misoprostol—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00254	CcSEcCtD
Misoprostol—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00254	CcSEcCtD
Misoprostol—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00253	CcSEcCtD
Misoprostol—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00252	CcSEcCtD
Misoprostol—Infection—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00252	CcSEcCtD
Misoprostol—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.0025	CcSEcCtD
Misoprostol—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.0025	CcSEcCtD
Misoprostol—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.0025	CcSEcCtD
Misoprostol—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00249	CcSEcCtD
Misoprostol—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.00249	CcSEcCtD
Misoprostol—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00249	CcSEcCtD
Misoprostol—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00249	CcSEcCtD
Misoprostol—Infection—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00247	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00105	0.00469	CbGpPWpGaD
Misoprostol—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00246	CcSEcCtD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00104	0.00464	CbGpPWpGaD
Misoprostol—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00243	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00103	0.0046	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00103	0.00457	CbGpPWpGaD
Misoprostol—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.0024	CcSEcCtD
Misoprostol—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.0024	CcSEcCtD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00102	0.00455	CbGpPWpGaD
Misoprostol—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00238	CcSEcCtD
Misoprostol—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00237	CcSEcCtD
Misoprostol—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00237	CcSEcCtD
Misoprostol—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00236	CcSEcCtD
Misoprostol—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00235	CcSEcCtD
Misoprostol—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00099	0.00232	CcSEcCtD
Misoprostol—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00099	0.00232	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000988	0.00231	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000988	0.00231	CcSEcCtD
Misoprostol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000975	0.00228	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000972	0.00433	CbGpPWpGaD
Misoprostol—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000971	0.00227	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000968	0.00226	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000967	0.00431	CbGpPWpGaD
Misoprostol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000967	0.00226	CcSEcCtD
Misoprostol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000967	0.00226	CcSEcCtD
Misoprostol—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000964	0.00226	CcSEcCtD
Misoprostol—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000964	0.00226	CcSEcCtD
Misoprostol—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000957	0.00224	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000956	0.00426	CbGpPWpGaD
Misoprostol—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000955	0.00223	CcSEcCtD
Misoprostol—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000955	0.00223	CcSEcCtD
Misoprostol—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000944	0.00221	CcSEcCtD
Misoprostol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000942	0.0022	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000942	0.0042	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000939	0.00418	CbGpPWpGaD
Misoprostol—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000935	0.00219	CcSEcCtD
Misoprostol—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000935	0.00219	CcSEcCtD
Misoprostol—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000935	0.00219	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000933	0.00218	CcSEcCtD
Misoprostol—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000928	0.00217	CcSEcCtD
Misoprostol—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000928	0.00217	CcSEcCtD
Misoprostol—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000928	0.00217	CcSEcCtD
Misoprostol—Pain—Formoterol—chronic obstructive pulmonary disease	0.000928	0.00217	CcSEcCtD
Misoprostol—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000916	0.00214	CcSEcCtD
Misoprostol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000913	0.00214	CcSEcCtD
Misoprostol—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00091	0.00213	CcSEcCtD
Misoprostol—Pain—Montelukast—chronic obstructive pulmonary disease	0.000908	0.00213	CcSEcCtD
Misoprostol—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000908	0.00212	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000908	0.00404	CbGpPWpGaD
Misoprostol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000906	0.00212	CcSEcCtD
Misoprostol—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000903	0.00211	CcSEcCtD
Misoprostol—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000903	0.00211	CcSEcCtD
Misoprostol—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000901	0.00211	CcSEcCtD
Misoprostol—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000901	0.00211	CcSEcCtD
Misoprostol—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000899	0.0021	CcSEcCtD
Misoprostol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000898	0.0021	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000897	0.004	CbGpPWpGaD
Misoprostol—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000895	0.00209	CcSEcCtD
Misoprostol—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000894	0.00209	CcSEcCtD
Misoprostol—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000894	0.00209	CcSEcCtD
Misoprostol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000893	0.00209	CcSEcCtD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000893	0.00398	CbGpPWpGaD
Misoprostol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000889	0.00208	CcSEcCtD
Misoprostol—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000887	0.00207	CcSEcCtD
Misoprostol—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000887	0.00207	CcSEcCtD
Misoprostol—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000883	0.00207	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000882	0.00393	CbGpPWpGaD
Misoprostol—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000876	0.00205	CcSEcCtD
Misoprostol—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000876	0.00205	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00087	0.00387	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000869	0.00203	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000868	0.00203	CcSEcCtD
Misoprostol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000857	0.00201	CcSEcCtD
Misoprostol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000857	0.00201	CcSEcCtD
Misoprostol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000857	0.00201	CcSEcCtD
Misoprostol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000857	0.00201	CcSEcCtD
Misoprostol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000854	0.002	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000849	0.00378	CbGpPWpGaD
Misoprostol—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000847	0.00198	CcSEcCtD
Misoprostol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000847	0.00198	CcSEcCtD
Misoprostol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000846	0.00198	CcSEcCtD
Misoprostol—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000844	0.00197	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000842	0.00375	CbGpPWpGaD
Misoprostol—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000842	0.00197	CcSEcCtD
Misoprostol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00084	0.00196	CcSEcCtD
Misoprostol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00084	0.00196	CcSEcCtD
Misoprostol—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000837	0.00196	CcSEcCtD
Misoprostol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00081	0.00189	CcSEcCtD
Misoprostol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00081	0.00189	CcSEcCtD
Misoprostol—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000799	0.00187	CcSEcCtD
Misoprostol—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000799	0.00187	CcSEcCtD
Misoprostol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000798	0.00187	CcSEcCtD
Misoprostol—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000797	0.00186	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000783	0.00349	CbGpPWpGaD
Misoprostol—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000783	0.00183	CcSEcCtD
Misoprostol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000778	0.00182	CcSEcCtD
Misoprostol—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000778	0.00182	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000777	0.00346	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000771	0.00343	CbGpPWpGaD
Misoprostol—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000762	0.00178	CcSEcCtD
Misoprostol—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000755	0.00177	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000745	0.00332	CbGpPWpGaD
Misoprostol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000742	0.00174	CcSEcCtD
Misoprostol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000742	0.00174	CcSEcCtD
Misoprostol—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000739	0.00173	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000737	0.00328	CbGpPWpGaD
Misoprostol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000735	0.00172	CcSEcCtD
Misoprostol—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000731	0.00171	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000728	0.00324	CbGpPWpGaD
Misoprostol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000727	0.0017	CcSEcCtD
Misoprostol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000717	0.00168	CcSEcCtD
Misoprostol—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000717	0.00168	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000711	0.00317	CbGpPWpGaD
Misoprostol—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000703	0.00164	CcSEcCtD
Misoprostol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000701	0.00164	CcSEcCtD
Misoprostol—PTGER3—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000694	0.00309	CbGpPWpGaD
Misoprostol—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000691	0.00162	CcSEcCtD
Misoprostol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00069	0.00161	CcSEcCtD
Misoprostol—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00069	0.00161	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000688	0.00306	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000688	0.00306	CbGpPWpGaD
Misoprostol—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000684	0.0016	CcSEcCtD
Misoprostol—Rash—Formoterol—chronic obstructive pulmonary disease	0.000684	0.0016	CcSEcCtD
Misoprostol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000683	0.0016	CcSEcCtD
Misoprostol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000683	0.0016	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00068	0.00303	CbGpPWpGaD
Misoprostol—Headache—Formoterol—chronic obstructive pulmonary disease	0.000679	0.00159	CcSEcCtD
Misoprostol—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000679	0.00159	CcSEcCtD
Misoprostol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000677	0.00158	CcSEcCtD
Misoprostol—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000675	0.00158	CcSEcCtD
Misoprostol—Rash—Montelukast—chronic obstructive pulmonary disease	0.00067	0.00157	CcSEcCtD
Misoprostol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000669	0.00157	CcSEcCtD
Misoprostol—Headache—Montelukast—chronic obstructive pulmonary disease	0.000666	0.00156	CcSEcCtD
Misoprostol—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00066	0.00154	CcSEcCtD
Misoprostol—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000656	0.00153	CcSEcCtD
Misoprostol—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000656	0.00153	CcSEcCtD
Misoprostol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000651	0.00152	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000648	0.00289	CbGpPWpGaD
Misoprostol—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000646	0.00151	CcSEcCtD
Misoprostol—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000645	0.00151	CcSEcCtD
Misoprostol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000645	0.00151	CcSEcCtD
Misoprostol—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000644	0.00151	CcSEcCtD
Misoprostol—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000644	0.00151	CcSEcCtD
Misoprostol—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000642	0.0015	CcSEcCtD
Misoprostol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000633	0.00148	CcSEcCtD
Misoprostol—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000631	0.00148	CcSEcCtD
Misoprostol—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000621	0.00145	CcSEcCtD
Misoprostol—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000608	0.00142	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000598	0.00266	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000589	0.00262	CbGpPWpGaD
Misoprostol—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000587	0.00137	CcSEcCtD
Misoprostol—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000587	0.00137	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000579	0.00258	CbGpPWpGaD
Misoprostol—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000578	0.00135	CcSEcCtD
Misoprostol—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000568	0.00133	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000565	0.00252	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000554	0.00247	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000554	0.00247	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000551	0.00246	CbGpPWpGaD
Misoprostol—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000543	0.00127	CcSEcCtD
Misoprostol—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000537	0.00126	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000532	0.00237	CbGpPWpGaD
Misoprostol—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000531	0.00124	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000526	0.00234	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000521	0.00232	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000507	0.00226	CbGpPWpGaD
Misoprostol—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000502	0.00118	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000491	0.00219	CbGpPWpGaD
Misoprostol—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000484	0.00113	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000484	0.00215	CbGpPWpGaD
Misoprostol—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000483	0.00113	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000476	0.00212	CbGpPWpGaD
Misoprostol—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000469	0.0011	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.00046	0.00205	CbGpPWpGaD
Misoprostol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00046	0.00108	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000455	0.00203	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000455	0.00203	CbGpPWpGaD
Misoprostol—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000452	0.00106	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000446	0.00199	CbGpPWpGaD
Misoprostol—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000445	0.00104	CcSEcCtD
Misoprostol—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000445	0.00104	CcSEcCtD
Misoprostol—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000444	0.00104	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000439	0.00196	CbGpPWpGaD
Misoprostol—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000433	0.00101	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000432	0.00192	CbGpPWpGaD
Misoprostol—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000427	0.000999	CcSEcCtD
Misoprostol—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000427	0.000999	CcSEcCtD
Misoprostol—Infection—Prednisone—chronic obstructive pulmonary disease	0.000424	0.000992	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00042	0.00187	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00042	0.00187	CbGpPWpGaD
Misoprostol—Shock—Prednisone—chronic obstructive pulmonary disease	0.00042	0.000982	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000416	0.00185	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000413	0.000965	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000405	0.00181	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000399	0.00178	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000389	0.00091	CcSEcCtD
Misoprostol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000388	0.000909	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000384	0.00171	CbGpPWpGaD
Misoprostol—Dinoprostone—CYP1A2—chronic obstructive pulmonary disease	0.000379	1	CrCbGaD
Misoprostol—PTGER2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000378	0.00168	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000377	0.00168	CbGpPWpGaD
Misoprostol—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000376	0.000879	CcSEcCtD
Misoprostol—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.000866	CcSEcCtD
Misoprostol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.000866	CcSEcCtD
Misoprostol—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000368	0.000861	CcSEcCtD
Misoprostol—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000368	0.000861	CcSEcCtD
Misoprostol—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000365	0.000854	CcSEcCtD
Misoprostol—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000352	0.000823	CcSEcCtD
Misoprostol—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000349	0.000817	CcSEcCtD
Misoprostol—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000349	0.000816	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000349	0.00155	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000348	0.00155	CbGpPWpGaD
Misoprostol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000337	0.000789	CcSEcCtD
Misoprostol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000337	0.000789	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000333	0.00148	CbGpPWpGaD
Misoprostol—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000314	0.000736	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000313	0.0014	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000311	0.00138	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.00031	0.00138	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000307	0.00137	CbGpPWpGaD
Misoprostol—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000306	0.000716	CcSEcCtD
Misoprostol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000683	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000286	0.00127	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000286	0.00127	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000284	0.00127	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000283	0.00126	CbGpPWpGaD
Misoprostol—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000282	0.00066	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000272	0.00121	CbGpPWpGaD
Misoprostol—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000271	0.000635	CcSEcCtD
Misoprostol—Rash—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00063	CcSEcCtD
Misoprostol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000629	CcSEcCtD
Misoprostol—Headache—Prednisone—chronic obstructive pulmonary disease	0.000267	0.000626	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000264	0.00117	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000257	0.00115	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000255	0.00114	CbGpPWpGaD
Misoprostol—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000254	0.000593	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000253	0.00113	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000237	0.00106	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000236	0.00105	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000234	0.00104	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000232	0.00103	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000223	0.000995	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000216	0.00096	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000214	0.000954	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000208	0.000926	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000208	0.000925	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000206	0.000918	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000198	0.000884	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000192	0.000853	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000189	0.000844	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000171	0.00076	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000168	0.000748	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000163	0.000726	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.00016	0.000712	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000158	0.000702	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000156	0.000693	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000152	0.000677	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.00015	0.00067	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000144	0.000639	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000138	0.000615	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000136	0.000608	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000131	0.000584	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000127	0.000567	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000125	0.000558	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000125	0.000556	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000123	0.000547	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000121	0.000539	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000115	0.000513	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000112	0.000499	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000103	0.000461	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000103	0.000459	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000103	0.000458	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000101	0.000449	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.49e-05	0.000423	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.44e-05	0.00042	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.31e-05	0.000415	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.47e-05	0.000377	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.81e-05	0.000348	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.75e-05	0.000345	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.15e-05	0.000319	CbGpPWpGaD
